Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

3 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Effect of GSK958108 on ejaculatory latency time (ELT); NCT00861484 - Follow-up

- 06/06/2020 - 1 Formulaire, 14 Groupes Item, 167 Eléments de données, 1 Langue
Groupes Item: Date of visit, Vital signs, 12 lead ECG, Laboratory Procedures, Hematology finding, Laboratory Procedures, Chemistry, Clinical, Laboratory Procedures, Urinalysis, Laboratory Procedures, Hormones, Laboratory Procedures, Free Testosterone Measurement, Laboratory Procedures, Prolactin measurement, Nervous system structure, Evaluation, Ophthalmic examination and evaluation, Blinded Clinical Study, Status, Pregnancy, Information, Conclusion, Clinical Research
Study ID: 111155 Clinical Study ID: 111155 Study Title: A double blind, parallel group, placebo controlled study to evaluate the effect of a single oral dose of GSK958108 on ejaculatory latency time (ELT) in male patients suffering from premature ejaculation. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00861484 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK958108 , Placebo Trade Name: N/A Study Indication: Premature Ejaculation

Effect of GSK958108 on ejaculatory latency time (ELT); NCT00861484 - Dose

- 06/06/2020 - 1 Formulaire, 14 Groupes Item, 327 Eléments de données, 1 Langue
Groupes Item: Date of visit, Randomization, Numbers, Experimental drug, Vital signs, 12 lead ECG, Laboratory Procedures, Hematology finding, Laboratory Procedures, Chemistry, Clinical, Laboratory Procedures, Urinalysis, Laboratory Procedures, Hormones, Laboratory Procedures, Free Testosterone Measurement, Laboratory Procedures, Prolactin measurement, Pharmacokinetic aspects, Blood, Nervous system structure, Evaluation, Ejaculation, Response Latency, Time, Intravaginal
Study ID: 111155 Clinical Study ID: 111155 Study Title: A double blind, parallel group, placebo controlled study to evaluate the effect of a single oral dose of GSK958108 on ejaculatory latency time (ELT) in male patients suffering from premature ejaculation. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00861484 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK958108 , Placebo Trade Name: N/A Study Indication: Premature Ejaculation

Emergency Room Point B in Time Part 1: Emergency Room Report UKM

- 03/07/2016 - 1 Formulaire, 15 Groupes Item, 119 Eléments de données, 2 Langues
Groupes Item: Patient information, Emergency Room Team, Medical history, Vital signs, Surgical interventions until admission in ICU, Diagnostics until admission in ICU, Neurological examination, Blood test, Clinical course, ASA, Therapy, Hemostasis Therapy, Further treatment, Urinary diversion, PTS
Report/Protocol collecting patient and treatment information like the circumstances of the accident and initial ER treatment. http://klinikum.uni-muenster.de/

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial